QR код

Access and Benefit Sharing Under the Nagoya Protocol—Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk

BackgroundGlobal challenges related to access and benefit sharing (ABS) of biological resources have become a key concern in the area of research on herbal medicines, ethnopharmacology, drug discovery, and the development of other high value products for which Intellectual Property protection can be...

Повний опис

Збережено в:
Автори: Michael Heinrich, Francesca Scotti, Adolfo Andrade-Cetto, Monica Berger-Gonzalez, Javier Echeverría, Fabio Friso, Felipe Garcia-Cardona, Alan Hesketh, Martin Hitziger, Caroline Maake, Matteo Politi, Carmenza Spadafora, Rita Spadafora
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2020-06-01
Серія:Frontiers in Pharmacology
Предмети:
Nagoya Protocol
benefit sharing
traditional medicine
Access and Benefit Sharing (ABS)
natural products
biological resources
Онлайн доступ:https://www.frontiersin.org/article/10.3389/fphar.2020.00765/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси